Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1456 entries
Sorted by: Best Match Show Resources per page
National minorities and their representation in social surveys: which practices make a difference?

Minority STEM

Penic S.
GSID: 1SKwzlT0IgkJ
F Laganà, G Elcheroth, S Penic, B Kleiner, N Fasel - Quality & Quantity, 2013 - Springer

… Individuals who are still in training were classified in a fourth, residual category (whose … In this part of the world, more than elsewhere, do so-called ethnic minorities stem from relatively …

Cite
Laganà, F., Elcheroth, G., Penic, S., Kleiner, B., & Fasel, N. (2013). National minorities and their representation in social surveys: which practices make a difference?. Quality & Quantity, 47, 1287-1314.
Laganà, Francesco, et al. "National minorities and their representation in social surveys: which practices make a difference?." Quality & Quantity 47 (2013): 1287-1314.
Copy Download .nbib Format: MLA
Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study.

Endoscopy international open

Kumbhari V, Tieu AH, Onimaru M, El Zein MH, Teitelbaum EN, Ujiki MB, Gitelis ME, Modayil RJ, Hungness ES, Stavropoulos SN, Shiwaku H, Kunda R, Chiu P, Saxena P, Messallam AA, Inoue H, Khashab MA.
PMID: 26171430
Endosc Int Open. 2015 Jun;3(3):E195-201. doi: 10.1055/s-0034-1391668. Epub 2015 Apr 13.

BACKGROUND AND STUDY AIMS: Type III achalasia is characterized by rapidly propagating pressurization attributable to spastic contractions. Although laparoscopic Heller myotomy (LHM) is the current gold standard management for type III achalasia, peroral endoscopic myotomy (POEM) is conceivably superior...

Cite
Kumbhari V, Tieu AH, Onimaru M, et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open. 2015;3(3):E195-201doi: 10.1055/s-0034-1391668.
Kumbhari, V., Tieu, A. H., Onimaru, M., El Zein, M. H., Teitelbaum, E. N., Ujiki, M. B., Gitelis, M. E., Modayil, R. J., Hungness, E. S., Stavropoulos, S. N., Shiwaku, H., Kunda, R., Chiu, P., Saxena, P., Messallam, A. A., Inoue, H., & Khashab, M. A. (2015). Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endoscopy international open, 3(3), E195-201. https://doi.org/10.1055/s-0034-1391668
Kumbhari, Vivek, et al. "Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study." Endoscopy international open vol. 3,3 (2015): E195-201. doi: https://doi.org/10.1055/s-0034-1391668
Kumbhari V, Tieu AH, Onimaru M, El Zein MH, Teitelbaum EN, Ujiki MB, Gitelis ME, Modayil RJ, Hungness ES, Stavropoulos SN, Shiwaku H, Kunda R, Chiu P, Saxena P, Messallam AA, Inoue H, Khashab MA. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open. 2015 Jun;3(3):E195-201. doi: 10.1055/s-0034-1391668. Epub 2015 Apr 13. PMID: 26171430; PMCID: PMC4486039.
Copy Download .nbib Format: NLM
Update on Foregut Molecular Embryology and Role of Regenerative Medicine Therapies.

Frontiers in pediatrics

Perin S, McCann CJ, Borrelli O, De Coppi P, Thapar N.
PMID: 28503544
Front Pediatr. 2017 Apr 28;5:91. doi: 10.3389/fped.2017.00091. eCollection 2017.

Esophageal atresia (OA) represents one of the commonest and most severe developmental disorders of the foregut, the most proximal segment of the gastrointestinal (GI) tract (esophagus and stomach) in embryological terms. Of intrigue is the common origin from this...

Cite
Perin S, McCann CJ, Borrelli O, et al. Update on Foregut Molecular Embryology and Role of Regenerative Medicine Therapies. Front Pediatr. 2017;5:91doi: 10.3389/fped.2017.00091.
Perin, S., McCann, C. J., Borrelli, O., De Coppi, P., & Thapar, N. (2017). Update on Foregut Molecular Embryology and Role of Regenerative Medicine Therapies. Frontiers in pediatrics, 591. https://doi.org/10.3389/fped.2017.00091
Perin, Silvia, et al. "Update on Foregut Molecular Embryology and Role of Regenerative Medicine Therapies." Frontiers in pediatrics vol. 5 (2017): 91. doi: https://doi.org/10.3389/fped.2017.00091
Perin S, McCann CJ, Borrelli O, De Coppi P, Thapar N. Update on Foregut Molecular Embryology and Role of Regenerative Medicine Therapies. Front Pediatr. 2017 Apr 28;5:91. doi: 10.3389/fped.2017.00091. eCollection 2017. PMID: 28503544; PMCID: PMC5408018.
Copy Download .nbib Format: NLM
Reply.

Journal of the Chinese Medical Association : JCMA

Paunic T, Peric S, Cvitan E, Raspopovic S, Peric M, Mandic Stojmenovic G, Rakocevic Stojanovic V.
PMID: 28951122
J Chin Med Assoc. 2017 Nov;80(11):742-743. doi: 10.1016/j.jcma.2017.08.001. Epub 2017 Sep 23.

No abstract available.

Cite
Paunic T, Peric S, Cvitan E, et al. Reply. J Chin Med Assoc. 2017;80(11):742-743doi: 10.1016/j.jcma.2017.08.001.
Paunic, T., Peric, S., Cvitan, E., Raspopovic, S., Peric, M., Mandic Stojmenovic, G., & Rakocevic Stojanovic, V. (2017). Reply. Journal of the Chinese Medical Association : JCMA, 80(11), 742-743. https://doi.org/10.1016/j.jcma.2017.08.001
Paunic, Teodora, et al. "Reply." Journal of the Chinese Medical Association : JCMA vol. 80,11 (2017): 742-743. doi: https://doi.org/10.1016/j.jcma.2017.08.001
Paunic T, Peric S, Cvitan E, Raspopovic S, Peric M, Mandic Stojmenovic G, Rakocevic Stojanovic V. Reply. J Chin Med Assoc. 2017 Nov;80(11):742-743. doi: 10.1016/j.jcma.2017.08.001. Epub 2017 Sep 23. PMID: 28951122.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Enterotoxigenic Escherichia coli Myophage Murica.

Genome announcements

Wilder JN, Lancaster JC, Cahill JL, Rasche ES, Kuty Everett GF.
PMID: 26430048
Genome Announc. 2015 Oct 01;3(5). doi: 10.1128/genomeA.01135-15.

Murica is an rv5-like myophage that infects enterotoxigenic Escherichia coli. Pathogenic E. coli strains are responsible for many intestinal diseases, and phages that infect these bacteria may prove useful in preventing severe health issues. The following is a report...

Cite
Wilder JN, Lancaster JC, Cahill JL, et al. Complete Genome Sequence of Enterotoxigenic Escherichia coli Myophage Murica. Genome Announc. 2015;3(5)doi: 10.1128/genomeA.01135-15.
Wilder, J. N., Lancaster, J. C., Cahill, J. L., Rasche, E. S., & Kuty Everett, G. F. (2015). Complete Genome Sequence of Enterotoxigenic Escherichia coli Myophage Murica. Genome announcements, 3(5), . https://doi.org/10.1128/genomeA.01135-15
Wilder, Joseph N, et al. "Complete Genome Sequence of Enterotoxigenic Escherichia coli Myophage Murica." Genome announcements vol. 3,5 (2015). doi: https://doi.org/10.1128/genomeA.01135-15
Wilder JN, Lancaster JC, Cahill JL, Rasche ES, Kuty Everett GF. Complete Genome Sequence of Enterotoxigenic Escherichia coli Myophage Murica. Genome Announc. 2015 Oct 01;3(5). doi: 10.1128/genomeA.01135-15. PMID: 26430048; PMCID: PMC4591320.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Carbapenemase-Producing Klebsiella pneumoniae Myophage Matisse.

Genome announcements

Provasek VE, Lessor LE, Cahill JL, Rasche ES, Kuty Everett GF.
PMID: 26430049
Genome Announc. 2015 Oct 01;3(5). doi: 10.1128/genomeA.01136-15.

Klebsiella pneumoniae is a leading cause of nosocomial infections in the United States. Due to the emergence of multidrug-resistant strains, phages targeting K. pneumoniae may be a useful alternative against this pathogen. Here, we announce the complete genome of...

Cite
Provasek VE, Lessor LE, Cahill JL, et al. Complete Genome Sequence of Carbapenemase-Producing Klebsiella pneumoniae Myophage Matisse. Genome Announc. 2015;3(5)doi: 10.1128/genomeA.01136-15.
Provasek, V. E., Lessor, L. E., Cahill, J. L., Rasche, E. S., & Kuty Everett, G. F. (2015). Complete Genome Sequence of Carbapenemase-Producing Klebsiella pneumoniae Myophage Matisse. Genome announcements, 3(5), . https://doi.org/10.1128/genomeA.01136-15
Provasek, Vincent E, et al. "Complete Genome Sequence of Carbapenemase-Producing Klebsiella pneumoniae Myophage Matisse." Genome announcements vol. 3,5 (2015). doi: https://doi.org/10.1128/genomeA.01136-15
Provasek VE, Lessor LE, Cahill JL, Rasche ES, Kuty Everett GF. Complete Genome Sequence of Carbapenemase-Producing Klebsiella pneumoniae Myophage Matisse. Genome Announc. 2015 Oct 01;3(5). doi: 10.1128/genomeA.01136-15. PMID: 26430049; PMCID: PMC4591321.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Myophage Miro.

Genome announcements

Mijalis EM, Lessor LE, Cahill JL, Rasche ES, Kuty Everett GF.
PMID: 26430050
Genome Announc. 2015 Oct 01;3(5). doi: 10.1128/genomeA.01137-15.

Klebsiella pneumoniae is a Gram-negative pathogen frequently associated with antibiotic-resistant nosocomial infections. Bacteriophage therapy against K. pneumoniae may be possible to combat these infections. The following describes the complete genome sequence and key features of the pseudo-T-even K. pneumoniae...

Cite
Mijalis EM, Lessor LE, Cahill JL, et al. Complete Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Myophage Miro. Genome Announc. 2015;3(5)doi: 10.1128/genomeA.01137-15.
Mijalis, E. M., Lessor, L. E., Cahill, J. L., Rasche, E. S., & Kuty Everett, G. F. (2015). Complete Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Myophage Miro. Genome announcements, 3(5), . https://doi.org/10.1128/genomeA.01137-15
Mijalis, Eleni M, et al. "Complete Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Myophage Miro." Genome announcements vol. 3,5 (2015). doi: https://doi.org/10.1128/genomeA.01137-15
Mijalis EM, Lessor LE, Cahill JL, Rasche ES, Kuty Everett GF. Complete Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Myophage Miro. Genome Announc. 2015 Oct 01;3(5). doi: 10.1128/genomeA.01137-15. PMID: 26430050; PMCID: PMC4591322.
Copy Download .nbib Format: NLM
Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts.

Reviews in urology

Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA.
PMID: 25009446
Rev Urol. 2014;16(2):67-75.

Proton beam therapy for prostate cancer has become a source of controversy in the urologic community, and the rapid dissemination and marketing of this technology has led to many patients inquiring about this therapy. Yet the complexity of the...

Cite
Wisenbaugh ES, Andrews PE, Ferrigni RG, et al. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014;16(2):67-75
Wisenbaugh, E. S., Andrews, P. E., Ferrigni, R. G., Schild, S. E., Keole, S. R., Wong, W. W., & Vora, S. A. (2014). Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Reviews in urology, 16(2), 67-75.
Wisenbaugh, Eric S, et al. "Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts." Reviews in urology vol. 16,2 (2014): 67-75.
Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014;16(2):67-75. PMID: 25009446; PMCID: PMC4080851.
Copy Download .nbib Format: NLM
Cryoablation of anteroseptal accessory pathways with a his bundle electrogram on the ablation catheter.

Indian pacing and electrophysiology journal

Liberman L, Spar DS, Nash MC, Silver ES.
PMID: 25609896
Indian Pacing Electrophysiol J. 2014 Dec 05;14(6):284-90. doi: 10.1016/s0972-6292(16)30816-6. eCollection 2014.

BACKGROUND: Radiofrequency catheter ablations of anteroseptal (AS) accessory pathways (AP) in pediatric patients have higher incidence of atrioventricular (AV) block than other AP locations. We report our experience using cryoablation in pediatric patients where a His bundle electrogram was...

Cite
Liberman L, Spar DS, Nash MC, et al. Cryoablation of anteroseptal accessory pathways with a his bundle electrogram on the ablation catheter. Indian Pacing Electrophysiol J. 2014;14(6):284-90doi: 10.1016/s0972-6292(16)30816-6.
Liberman, L., Spar, D. S., Nash, M. C., & Silver, E. S. (2014). Cryoablation of anteroseptal accessory pathways with a his bundle electrogram on the ablation catheter. Indian pacing and electrophysiology journal, 14(6), 284-90. https://doi.org/10.1016/s0972-6292(16)30816-6
Liberman, Leonardo, et al. "Cryoablation of anteroseptal accessory pathways with a his bundle electrogram on the ablation catheter." Indian pacing and electrophysiology journal vol. 14,6 (2014): 284-90. doi: https://doi.org/10.1016/s0972-6292(16)30816-6
Liberman L, Spar DS, Nash MC, Silver ES. Cryoablation of anteroseptal accessory pathways with a his bundle electrogram on the ablation catheter. Indian Pacing Electrophysiol J. 2014 Dec 05;14(6):284-90. doi: 10.1016/s0972-6292(16)30816-6. eCollection 2014. PMID: 25609896; PMCID: PMC4286952.
Copy Download .nbib Format: NLM
Tyrosine kinase inhibitor induced isolated pericardial effusion.

Case reports in oncology

Agrawal V, Christenson ES, Showel MM.
PMID: 25848358
Case Rep Oncol. 2015 Feb 13;8(1):88-93. doi: 10.1159/000375484. eCollection 2015.

Long-term therapy with tyrosine kinase inhibitors (TKI) has resulted in improved outcomes for patients suffering from Bcr-Abl fusion protein-harboring leukemias. As a result, a growing population of patients on TKI therapy present to their primary care providers. In this...

Cite
Agrawal V, Christenson ES, Showel MM. Tyrosine kinase inhibitor induced isolated pericardial effusion. Case Rep Oncol. 2015;8(1):88-93doi: 10.1159/000375484.
Agrawal, V., Christenson, E. S., & Showel, M. M. (2015). Tyrosine kinase inhibitor induced isolated pericardial effusion. Case reports in oncology, 8(1), 88-93. https://doi.org/10.1159/000375484
Agrawal, Vineet, et al. "Tyrosine kinase inhibitor induced isolated pericardial effusion." Case reports in oncology vol. 8,1 (2015): 88-93. doi: https://doi.org/10.1159/000375484
Agrawal V, Christenson ES, Showel MM. Tyrosine kinase inhibitor induced isolated pericardial effusion. Case Rep Oncol. 2015 Feb 13;8(1):88-93. doi: 10.1159/000375484. eCollection 2015. PMID: 25848358; PMCID: PMC4361914.
Copy Download .nbib Format: NLM
Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery.

Pain and therapy

Edwards ET, Edwards ES, Davis E, Mulcare M, Wiklund M, Kelley G.
PMID: 25910473
Pain Ther. 2015 Jun;4(1):89-105. doi: 10.1007/s40122-015-0035-9. Epub 2015 Apr 25.

INTRODUCTION: The standard of care for reversal of opioid-induced respiratory depression associated with opioid overdose is injectable naloxone. This study compared the usability of two naloxone delivery devices, a naloxone auto-injector (NAI) and a naloxone intranasal delivery system (NXN),...

Cite
Edwards ET, Edwards ES, Davis E, et al. Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery. Pain Ther. 2015;4(1):89-105doi: 10.1007/s40122-015-0035-9.
Edwards, E. T., Edwards, E. S., Davis, E., Mulcare, M., Wiklund, M., & Kelley, G. (2015). Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery. Pain and therapy, 4(1), 89-105. https://doi.org/10.1007/s40122-015-0035-9
Edwards, Evan T, et al. "Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery." Pain and therapy vol. 4,1 (2015): 89-105. doi: https://doi.org/10.1007/s40122-015-0035-9
Edwards ET, Edwards ES, Davis E, Mulcare M, Wiklund M, Kelley G. Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery. Pain Ther. 2015 Jun;4(1):89-105. doi: 10.1007/s40122-015-0035-9. Epub 2015 Apr 25. PMID: 25910473; PMCID: PMC4470965.
Copy Download .nbib Format: NLM
Esophagogastric junction distensibility measured by a functional lumen imaging probe with incremental gastric myotomy lengths in achalasia.

Surgical endoscopy

Khoury RE, Sternbach JM, Teitelbaum EN, Soper NJ, Hungness ES.
PMID: 26201416
Surg Endosc. 2016 May;30(5):2139-40. doi: 10.1007/s00464-015-4437-x. Epub 2015 Jul 23.

No abstract available.

Cite
Khoury RE, Sternbach JM, Teitelbaum EN, et al. Esophagogastric junction distensibility measured by a functional lumen imaging probe with incremental gastric myotomy lengths in achalasia. Surg Endosc. 2015;30(5):2139-40doi: 10.1007/s00464-015-4437-x.
Khoury, R. E., Sternbach, J. M., Teitelbaum, E. N., Soper, N. J., & Hungness, E. S. (2016). Esophagogastric junction distensibility measured by a functional lumen imaging probe with incremental gastric myotomy lengths in achalasia. Surgical endoscopy, 30(5), 2139-40. https://doi.org/10.1007/s00464-015-4437-x
Khoury, Rym El, et al. "Esophagogastric junction distensibility measured by a functional lumen imaging probe with incremental gastric myotomy lengths in achalasia." Surgical endoscopy vol. 30,5 (2016): 2139-40. doi: https://doi.org/10.1007/s00464-015-4437-x
Khoury RE, Sternbach JM, Teitelbaum EN, Soper NJ, Hungness ES. Esophagogastric junction distensibility measured by a functional lumen imaging probe with incremental gastric myotomy lengths in achalasia. Surg Endosc. 2016 May;30(5):2139-40. doi: 10.1007/s00464-015-4437-x. Epub 2015 Jul 23. PMID: 26201416.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1456 entries